Xolair (omalizumab) - Roche, Novartis
barzolvolimab (CDX-0159) - Celldex
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/41877821
 
Alexandre Ton That; Catherine Keying Zhu; Elena Netchiporouk; Ethan Bendayan; Moshe Ben-Shoshan
 
Mar 25, 2026
 
Prev Next